{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:03:52Z","timestamp":1771434232803,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-026-00535-6","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:33:17Z","timestamp":1771219997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does bilateral mastectomy affect clinical outcomes in BRCA1\/2 mutation carriers with primary breast cancer? A systematic review and meta-analysis"],"prefix":"10.1007","volume":"25","author":[{"given":"Pedro Henrique","family":"de Souza Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Tadeu","family":"Freitas Uch\u00f4a Matheus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Zimermann Kamitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Lucas","family":"Azevedo de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Cezar Aquino","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"535_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"535_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"535_CR3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V et al (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med 31:1154\u20131162. https:\/\/doi.org\/10.1038\/s41591-025-03502-3","journal-title":"Nat Med"},{"key":"535_CR4","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/s41416-024-02827-z","volume":"131","author":"B Arun","year":"2024","unstructured":"Arun B, Couch FJ, Abraham J et al (2024) BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing. Br J Cancer 131:1400\u20131414. https:\/\/doi.org\/10.1038\/s41416-024-02827-z","journal-title":"Br J Cancer"},{"key":"535_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1158\/2159-8290.CD-24-1326","volume":"15","author":"SC Moser","year":"2025","unstructured":"Moser SC, Jonkers J (2025) Thirty years of BRCA1: mechanistic insights and their impact on mutation carriers. Cancer Discov 15:461\u2013480. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-1326","journal-title":"Cancer Discov"},{"key":"535_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401\u20131408. https:\/\/doi.org\/10.1056\/NEJM199705153362001","journal-title":"N Engl J Med"},{"key":"535_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1200\/JCO.24.01146","volume":"43","author":"I Allen","year":"2025","unstructured":"Allen I, Hassan H, Walburga Y et al (2025) Second primary cancer risks after breast cancer in BRCA1 and BRCA2 pathogenic variant carriers. J Clin Oncol 43:651\u2013661. https:\/\/doi.org\/10.1200\/JCO.24.01146","journal-title":"J Clin Oncol"},{"key":"535_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108603","volume":"50","author":"L Cortesi","year":"2024","unstructured":"Cortesi L, Cortesi G, Venturelli M et al (2024) Can contralateral prophylactic mastectomy and oophorectomy increase survival in BRCA-related breast cancer? Results from the Italian MUTina study. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 50:108603. https:\/\/doi.org\/10.1016\/j.ejso.2024.108603","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"535_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s12935-021-02194-2","volume":"21","author":"Z Jia","year":"2021","unstructured":"Jia Z, Li J, Zhang Y et al (2021) Contralateral risk-reducing local therapy in breast cancer patients with BRCA1\/2 mutations: systemic review and meta-analysis. Cancer Cell Int 21:512. https:\/\/doi.org\/10.1186\/s12935-021-02194-2","journal-title":"Cancer Cell Int"},{"key":"535_CR10","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/annonc\/mdt134","volume":"24","author":"BaM Heemskerk-Gerritsen","year":"2013","unstructured":"Heemskerk-Gerritsen BaM, Menke-Pluijmers MBE, Jager A et al (2013) Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis. Ann Oncol 24:2029\u20132035. https:\/\/doi.org\/10.1093\/annonc\/mdt134","journal-title":"Ann Oncol"},{"key":"535_CR11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/biology11101461","volume":"11","author":"A Bilyalov","year":"2022","unstructured":"Bilyalov A, Nikolaev S, Shigapova L et al (2022) Application of multigene panels testing for hereditary cancer syndromes. Biology 11:1461. https:\/\/doi.org\/10.3390\/biology11101461","journal-title":"Biology"},{"key":"535_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/978-981-32-9620-6_24","volume":"1187","author":"E-S Lee","year":"2021","unstructured":"Lee E-S, Kim J, Han W (2021) Multigene panel testing for hereditary cancer and genetic counseling. Adv Exp Med Biol 1187:455\u2013471. https:\/\/doi.org\/10.1007\/978-981-32-9620-6_24","journal-title":"Adv Exp Med Biol"},{"key":"535_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","volume":"21","author":"MB Daly","year":"2023","unstructured":"Daly MB, Pal T, Maxwell KN et al (2023) NCCN Guidelines\u00ae Insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024. J Natl Compr Canc Netw 21:1000\u20131010. https:\/\/doi.org\/10.6004\/jnccn.2023.0051","journal-title":"J Natl Compr Canc Netw"},{"key":"535_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","volume":"34","author":"C Sessa","year":"2023","unstructured":"Sessa C, Balma\u00f1a J, Bober SL et al (2023) Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO clinical practice guideline. Ann Oncol Off J Eur Soc Med Oncol 34:33\u201347. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.004","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"535_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1447545","volume":"2022","author":"S Makhnoon","year":"2022","unstructured":"Makhnoon S, Gutierrez Barrera AM, Bassett R et al (2022) Contralateral prophylactic mastectomy among women with pathogenic variants in BRCA1\/2: overall survival, racial, and ethnic differences. Breast J 2022:1447545. https:\/\/doi.org\/10.1155\/2022\/1447545","journal-title":"Breast J"},{"key":"535_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/jnci\/djq018","volume":"102","author":"I Bedrosian","year":"2010","unstructured":"Bedrosian I, Hu C-Y, Chang GJ (2010) Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 102:401\u2013409. https:\/\/doi.org\/10.1093\/jnci\/djq018","journal-title":"J Natl Cancer Inst"},{"key":"535_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10549-013-2745-1","volume":"142","author":"K Yao","year":"2013","unstructured":"Yao K, Winchester DJ, Czechura T, Huo D (2013) Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998\u20132002. Breast Cancer Res Treat 142:465\u2013476. https:\/\/doi.org\/10.1007\/s10549-013-2745-1","journal-title":"Breast Cancer Res Treat"},{"key":"535_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju160","volume":"106","author":"PR Portschy","year":"2014","unstructured":"Portschy PR, Kuntz KM, Tuttle TM (2014) Survival outcomes after contralateral prophylactic mastectomy: a decision analysis. J Natl Cancer Inst 106:dju160. https:\/\/doi.org\/10.1093\/jnci\/dju160","journal-title":"J Natl Cancer Inst"},{"key":"535_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S1470-2045(25)00152-4","volume":"26","author":"E Blondeaux","year":"2025","unstructured":"Blondeaux E, Sonnenblick A, Agostinetto E et al (2025) Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study. Lancet Oncol 26:759\u2013770. https:\/\/doi.org\/10.1016\/S1470-2045(25)00152-4","journal-title":"Lancet Oncol"},{"key":"535_CR20","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1245\/s10434-022-13056-0","volume":"30","author":"GA Fasano","year":"2023","unstructured":"Fasano GA, Bayard S, Chen Y et al (2023) Survival outcomes in women with unilateral, triple-negative, breast cancer correlated with contralateral prophylactic mastectomy. Ann Surg Oncol 30:4648\u20134656. https:\/\/doi.org\/10.1245\/s10434-022-13056-0","journal-title":"Ann Surg Oncol"},{"key":"535_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/sj.bjc.6602703","volume":"93","author":"TC van Sprundel","year":"2005","unstructured":"van Sprundel TC, Schmidt MK, Rookus MA et al (2005) Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 93:287\u2013292. https:\/\/doi.org\/10.1038\/sj.bjc.6602703","journal-title":"Br J Cancer"},{"key":"535_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1200\/JCO.20.02239","volume":"39","author":"GD Sacks","year":"2021","unstructured":"Sacks GD, Morrow M (2021) Addressing the dilemma of contralateral prophylactic mastectomy with behavioral science. J Clin Oncol Off J Am Soc Clin Oncol 39:269\u2013272. https:\/\/doi.org\/10.1200\/JCO.20.02239","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"535_CR23","doi-asserted-by":"publisher","unstructured":"Cumpston M, Li T, Page MJ et al (2019) Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev 10:ED000142. https:\/\/doi.org\/10.1002\/14651858.ED000142","DOI":"10.1002\/14651858.ED000142"},{"key":"535_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"535_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535","journal-title":"BMJ"},{"key":"535_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"535_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s44272-025-00030-6","volume":"4","author":"M-S Hosseini","year":"2025","unstructured":"Hosseini M-S (2025) Rethinking contralateral breast cancer: latest insights on risk, prevention, and outcomes. Clin Cancer Bull 4:3. https:\/\/doi.org\/10.1007\/s44272-025-00030-6","journal-title":"Clin Cancer Bull"},{"key":"535_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/sja.sja_715_23","volume":"18","author":"A Nair","year":"2024","unstructured":"Nair A, Borkar NK (2024) Understanding the trial sequential analysis graph in meta-analysis. Saudi J Anaesth 18:162\u2013164. https:\/\/doi.org\/10.4103\/sja.sja_715_23","journal-title":"Saudi J Anaesth"},{"key":"535_CR29","unstructured":"TSA\u2013ctu.dk. https:\/\/ctu.dk\/tsa\/. Accessed 20 Jan 2026"},{"key":"535_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"535_CR31","unstructured":"GRADE | Cochrane. https:\/\/www.cochrane.org\/learn\/courses-and-resources\/cochrane-methodology\/grade. Accessed 20 Jan 2026"},{"key":"535_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2023.101484","author":"M Prasad","year":"2024","unstructured":"Prasad M (2024) Introduction to the GRADE tool for rating certainty in evidence and recommendations. Clin Epidemiol Glob Health. https:\/\/doi.org\/10.1016\/j.cegh.2023.101484","journal-title":"Clin Epidemiol Glob Health"},{"key":"535_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"535_CR34","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/s0895-4356(01)00377-8","volume":"54","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54:1046\u20131055. https:\/\/doi.org\/10.1016\/s0895-4356(01)00377-8","journal-title":"J Clin Epidemiol"},{"key":"535_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22:153\u2013160. https:\/\/doi.org\/10.1136\/ebmental-2019-300117","journal-title":"Evid Based Ment Health"},{"key":"535_CR36","unstructured":"Chapter 10: Analysing data and undertaking meta-analyses | Cochrane. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-10. Accessed 20 Jan 2026"},{"key":"535_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2","journal-title":"Control Clin Trials"},{"key":"535_CR38","doi-asserted-by":"crossref","unstructured":"Page MJ, Higgins JP, Sterne JA (2019) Assessing risk of bias due to missing results in a synthesis. In: Cochrane handbook for systematic reviews of interventions. Wiley, pp 349\u2013374","DOI":"10.1002\/9781119536604.ch13"},{"key":"535_CR39","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","volume":"22","author":"K Metcalfe","year":"2004","unstructured":"Metcalfe K, Lynch HT, Ghadirian P et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol Off J Am Soc Clin Oncol 22:2328\u20132335. https:\/\/doi.org\/10.1200\/JCO.2004.04.033","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"535_CR40","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","volume":"177","author":"BAM Heemskerk-Gerritsen","year":"2019","unstructured":"Heemskerk-Gerritsen BAM, Jager A, Koppert LB et al (2019) Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 177:723\u2013733. https:\/\/doi.org\/10.1007\/s10549-019-05345-2","journal-title":"Breast Cancer Res Treat"},{"key":"535_CR41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41416-023-02503-8","volume":"130","author":"K Metcalfe","year":"2024","unstructured":"Metcalfe K, Huzarski T, Gronwald J et al (2024) Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. Br J Cancer 130:269\u2013274. https:\/\/doi.org\/10.1038\/s41416-023-02503-8","journal-title":"Br J Cancer"},{"key":"535_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00432-025-06231-9","volume":"151","author":"M Raposo","year":"2025","unstructured":"Raposo M, Peleteiro B, Magalh\u00e3es A et al (2025) Quality of life after risk reducing mastectomy in a Portuguese cohort of BRCA pathogenic\/likely pathogenic variant carriers. J Cancer Res Clin Oncol 151:177. https:\/\/doi.org\/10.1007\/s00432-025-06231-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"535_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32050269","volume":"32","author":"A-M Parger","year":"2025","unstructured":"Parger A-M, Gebhart P, Muhr D et al (2025) Treatment patterns, clinical outcomes and quality of life in BRCA1\/2-associated breast cancer patients: a retrospective analysis. Curr Oncol 32:269. https:\/\/doi.org\/10.3390\/curroncol32050269","journal-title":"Curr Oncol"},{"key":"535_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g226","volume":"348","author":"K Metcalfe","year":"2014","unstructured":"Metcalfe K, Gershman S, Ghadirian P et al (2014) Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ 348:g226. https:\/\/doi.org\/10.1136\/bmj.g226","journal-title":"BMJ"},{"key":"535_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-013-2583-1","volume":"140","author":"DGR Evans","year":"2013","unstructured":"Evans DGR, Ingham SL, Baildam A et al (2013) Contralateral mastectomy improves survival in women with BRCA1\/2-associated breast cancer. Breast Cancer Res Treat 140:135\u2013142. https:\/\/doi.org\/10.1007\/s10549-013-2583-1","journal-title":"Breast Cancer Res Treat"},{"key":"535_CR46","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1038\/s41416-020-01164-1","volume":"124","author":"DG Evans","year":"2021","unstructured":"Evans DG, Phillips K-A, Milne RL et al (2021) Survival from breast cancer in women with a BRCA2 mutation by treatment. Br J Cancer 124:1524\u20131532. https:\/\/doi.org\/10.1038\/s41416-020-01164-1","journal-title":"Br J Cancer"},{"key":"535_CR47","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/ijc.29032","volume":"136","author":"BAM Heemskerk-Gerritsen","year":"2015","unstructured":"Heemskerk-Gerritsen BAM, Rookus MA, Aalfs CM et al (2015) Improved overall survival after contralateral risk-reducing mastectomy in BRCA1\/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int J Cancer 136:668\u2013677. https:\/\/doi.org\/10.1002\/ijc.29032","journal-title":"Int J Cancer"},{"key":"535_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94195-4","volume":"11","author":"J Woo","year":"2021","unstructured":"Woo J, Gwak G, Park I et al (2021) Preoperative diagnosis of BRCA1\/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients. Sci Rep 11:14747. https:\/\/doi.org\/10.1038\/s41598-021-94195-4","journal-title":"Sci Rep"},{"key":"535_CR49","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.2270482","volume":"250","author":"JM Hall","year":"1990","unstructured":"Hall JM, Lee MK, Newman B et al (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684\u20131689. https:\/\/doi.org\/10.1126\/science.2270482","journal-title":"Science"},{"key":"535_CR50","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"M-C King","year":"2003","unstructured":"King M-C, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646. https:\/\/doi.org\/10.1126\/science.1088759","journal-title":"Science"},{"key":"535_CR51","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","volume":"90","author":"SR Lakhani","year":"1998","unstructured":"Lakhani SR, Jacquemier J, Sloane JP et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90:1138\u20131145. https:\/\/doi.org\/10.1093\/jnci\/90.15.1138","journal-title":"J Natl Cancer Inst"},{"key":"535_CR52","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402\u20132416. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"key":"535_CR53","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004975","volume":"95","author":"Z Baretta","year":"2016","unstructured":"Baretta Z, Mocellin S, Goldin E et al (2016) Effect of BRCA germline mutations on breast cancer prognosis: a systematic review and meta-analysis. Medicine (Baltimore) 95:e4975. https:\/\/doi.org\/10.1097\/MD.0000000000004975","journal-title":"Medicine (Baltimore)"},{"key":"535_CR54","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130. https:\/\/doi.org\/10.1086\/375033","journal-title":"Am J Hum Genet"},{"key":"535_CR55","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol Off J Am Soc Clin Oncol 22:1055\u20131062. https:\/\/doi.org\/10.1200\/JCO.2004.04.188","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"535_CR56","first-page":"997","volume":"277","author":"W Burke","year":"1997","unstructured":"Burke W, Daly M, Garber J et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genet Stud Consortium JAMA 277:997\u20131003","journal-title":"Cancer Genet Stud Consortium JAMA"},{"key":"535_CR57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3322\/canjclin.45.5.263","volume":"45","author":"MM Bilimoria","year":"1995","unstructured":"Bilimoria MM, Morrow M (1995) The woman at increased risk for breast cancer: evaluation and management strategies. CA Cancer J Clin 45:263\u2013278. https:\/\/doi.org\/10.3322\/canjclin.45.5.263","journal-title":"CA Cancer J Clin"},{"key":"535_CR58","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/s0959-8049(97)00360-2","volume":"33","author":"JG Klijn","year":"1997","unstructured":"Klijn JG, Janin N, Cort\u00e9s-Funes H, Colomer R (1997) Should prophylactic surgery be used in women with a high risk of breast cancer? Eur J Cancer Oxf Engl 1990 33:2149\u20132159. https:\/\/doi.org\/10.1016\/s0959-8049(97)00360-2","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"535_CR59","unstructured":"Reasons for prophylactic mastectomy in women carrying BRCA 1\/2 mutation: a systematic literature review. https:\/\/www.scirp.org\/journal\/paperinformation?paperid=33920. Accessed 20 Jan 2026"},{"key":"535_CR60","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1200\/JCO.2009.24.2495","volume":"28","author":"KE Malone","year":"2010","unstructured":"Malone KE, Begg CB, Haile RW et al (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 28:2404\u20132410. https:\/\/doi.org\/10.1200\/JCO.2009.24.2495","journal-title":"J Clin Oncol"},{"key":"535_CR61","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/SLA.0000000000001840","volume":"266","author":"AO Momoh","year":"2017","unstructured":"Momoh AO, Cohen WA, Kidwell KM et al (2017) Tradeoffs associated with contralateral prophylactic mastectomy in women choosing breast reconstruction: results of a prospective multicenter cohort. Ann Surg 266:158\u2013164. https:\/\/doi.org\/10.1097\/SLA.0000000000001840","journal-title":"Ann Surg"},{"key":"535_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-89068-z","volume":"15","author":"N Polidorio","year":"2025","unstructured":"Polidorio N, Sandoval RL, Bioni P et al (2025) Optimizing shared decision-making for risk-reducing mastectomy in women with Li-Fraumeni syndrome using patient-reported outcome measures. Sci Rep 15:19449. https:\/\/doi.org\/10.1038\/s41598-025-89068-z","journal-title":"Sci Rep"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00535-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00535-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00535-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:08:58Z","timestamp":1771430938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00535-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00535-6","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"21"}}